Abeona therapeutics inc. (ABEO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Revenues

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Expenses:
Total revenues

-

-

-

2,191

-

-

-

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foundation grants

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

30

30

0

0

0

Royalties

-

-

-

-

-

-

-

-

-

-

-

-

238

-

246

347

415

438

457

407

372

327

273

234

140

78

77

60

72

93

89

84

90

89

84

79

0

0

0

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,529

2,457

3,238

3,473

2,865

2,352

1,653

1,080

539

137

55

0

0

0

License revenues

-

-

-

-

-

-

-

-

-

-

-

-

602

-

602

602

602

602

602

603

603

598

593

585

519

435

352

270

246

1,446

1,455

2,329

2,356

1,181

1,217

368

0

0

0

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

840

-

848

949

1,017

1,040

1,059

1,010

975

925

853

806

1,026

2,042

2,886

3,568

3,791

4,404

3,896

4,066

3,526

1,839

1,468

532

0

0

0

Research and development

43,647

48,566

48,431

50,664

42,273

38,698

34,934

25,061

22,953

16,989

14,320

13,788

10,998

10,655

9,689

8,525

6,117

4,715

2,679

1,171

642

333

426

589

705

884

1,054

1,126

1,583

2,010

2,362

2,960

3,209

3,579

4,128

3,955

0

0

0

General and administrative

21,458

20,705

23,602

23,872

22,887

20,106

15,588

12,784

10,799

10,943

10,633

10,858

11,946

13,290

14,734

17,060

16,997

14,320

10,730

6,808

4,009

3,712

0

0

0

-

-

-

-

-

-

-

-

-

5,397

4,848

0

0

0

Product costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

125

191

263

273

267

159

141

115

148

190

129

0

0

0

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,834

5,650

6,430

5,699

6,024

0

0

0

-

-

-

-

-

-

Depreciation and amortization

8,226

7,819

7,138

5,611

3,844

2,360

1,115

748

665

741

843

927

901

825

727

656

607

551

410

260

129

11

3

2

2

3

330

348

366

419

148

186

226

233

235

238

0

0

0

Licensed technology impairment charge

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

-

-

-

80,147

-

-

-

38,593

34,417

-

25,796

25,573

23,845

24,770

25,150

26,241

23,721

19,586

13,819

8,239

4,780

4,056

4,201

4,217

5,655

5,846

7,225

8,167

7,921

8,720

8,683

9,681

9,942

9,715

9,950

9,170

0

0

0

Loss from operations

-106,247

-77,090

-78,689

-77,956

-66,537

-58,166

-48,906

-37,352

-33,235

-27,836

-24,918

-24,730

-23,005

-23,881

-24,302

-25,292

-22,704

-18,546

-12,760

-7,229

-3,805

-3,131

-3,348

-3,411

-4,629

-3,804

-4,339

-4,599

-4,130

-4,316

-4,787

-5,615

-6,416

-7,876

0

0

0

-

-

Interest and miscellaneous income

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other expense

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Interest and miscellaneous income

-

-

-

1,584

-

-

-

795

642

-

-944

1,586

1,435

2,014

7,097

4,638

4,641

4,026

111

30

40

45

81

116

165

251

345

410

335

242

155

1,327

1,330

1,334

1,329

558

0

0

0

Interest and other expense

-

-

-

5

-

-

-

9

9

-

9

8

6

6

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

461

582

503

452

358

279

266

356

482

608

727

778

965

963

912

818

0

0

0

Warrant extension expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,316

2,316

2,316

2,316

0

0

0

0

-

-

Gain on change in fair value of derivative-warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

140

36

248

1,236

0

0

0

-

-

-

-

-

-

Loss on change in fair value of derivative-preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23,110

-12,271

-11,150

3,813

8,010

29,471

15,150

2,470

-4,770

0

0

0

-

-

-

-

-

-

Gain on change in fair value of derivative-warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,458

5,681

0

0

0

Loss on change in fair value of derivative - preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,925

10,875

0

0

0

Total non operating income (expense)

-

-

-

-

-

-

-

-

-

-

-953

1,578

1,429

-

7,091

4,632

4,634

4,020

-11,369

-12,296

-24,114

-23,647

-12,562

-11,187

4,138

8,253

29,690

15,240

2,571

-6,216

-25,274

-9,229

908

5,361

-7,050

-5,454

0

0

0

Net loss

-105,886

-76,282

-77,330

-76,377

-64,696

-56,671

-47,642

-36,566

-32,602

-27,319

-25,871

-23,152

-21,576

-21,873

-17,211

-20,660

-18,070

-14,526

-24,129

-19,525

-27,919

-26,778

-15,910

-14,598

-491

4,449

25,351

10,641

-1,559

-10,532

-30,078

-14,861

-5,525

-2,532

-15,532

-14,092

0

0

0

Less preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,875

2,887

2,889

2,896

2,898

2,878

2,580

2,286

1,999

1,770

1,773

1,776

1,774

1,779

1,778

0

0

0

Net loss allocable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29,653

-18,797

-17,487

-3,387

1,551

22,473

8,061

-3,845

-12,531

-31,848

-16,634

-7,301

-4,306

-17,311

-15,870

0

0

0

Basic and diluted loss per common share

-0.52

-0.30

-0.35

-0.49

-0.39

-0.36

-0.34

-0.26

-0.22

-0.19

-0.13

-0.21

-0.13

-0.19

-0.08

-0.20

-0.17

-0.08

-0.19

-0.16

-0.10

17.21

-4.15

-25.26

-3.06

-

-

-

-

-

-

-

-

-

0.00

-0.09

-

-0.83

-

Weighted average number of common shares outstanding - basic and diluted

92,639

54,718

49,721

48,961

47,948

47,944

47,794

47,303

47,060

45,643

40,377

40,270

40,254

37,919

33,274

32,784

32,743

32,922

31,787

25,695

19,983

6,197

532

523

517

-

-

-

-

-

-

-

-

-

19,503

19,387

-

-

-

Other comprehensive income/(loss):
Change in unrealized gains related to available-for-sale debt securities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4.67

-1.77

0.03

0.14

0.79

-0.63

-0.46

-0.22

-

-

-

-0.12

-

0.09

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4.65

-1.77

0.03

0.13

0.79

-0.63

-0.46

-0.22

-

-

-

-0.12

-

0.07

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-48,401

508

25,111

24,800

24,235

24,173

24,160

24,145

-

-

-

19,241

-

15,460

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-49,096

508

25,469

25,156

24,235

24,173

24,160

24,145

-

-

-

19,241

-

27,937

Weighted average basic and diluted common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,774

-

Foundation Revenues [Member]
Total revenues

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties [Member]
Total revenues

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foundation revenues
Total revenues

-

-

-

0

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenues [Member]
Total revenues

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties
Total revenues

-

-

-

0

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-